NCT02941419View on ClinicalTrials.gov

Treatment of PAD by Platelet Lysate for Therapeutic Angiogenesis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 5, 2013

Primary Completion Date

September 15, 2016

Study Completion Date

February 9, 2017

Conditions
Critical Limb Ischemia
Interventions
BIOLOGICAL

Platelet lysate

Autologous intramuscular platelet lysate injection for patients with peripheral arterial disease

All Listed Sponsors
lead

University of Jordan

OTHER

NCT02941419 - Treatment of PAD by Platelet Lysate for Therapeutic Angiogenesis | Biotech Hunter | Biotech Hunter